Squalamine lactate is primarily utilized in medical and pharmaceutical applications due to its antimicrobial and antiangiogenic properties. It has been investigated for its potential in treating various types of cancer, as it inhibits the growth of blood vessels that supply tumors, effectively starving them. Additionally, it shows promise in combating viral infections, including certain strains of hepatitis and dengue, by disrupting viral replication. In ophthalmology, it is explored for treating age-related macular degeneration (AMD) by reducing abnormal blood vessel formation in the retina. Its broad-spectrum antimicrobial activity also makes it a candidate for addressing multidrug-resistant bacterial infections. Research continues to explore its therapeutic potential in other areas, including neurodegenerative diseases and inflammation.